- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
14-3-3 proteins stabilize LGI1-ADAM22 levels to regulate seizure thresholds in mice
-
- Yokoi, Norihiko
- Division of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences; Department of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies)
-
- Fukata, Yuko
- Division of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences; Department of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies)
-
- Okatsu, Kei
- Department of Chemistry, Graduate School of Science, Kyoto University
-
- Yamagata, Atsushi
- RIKEN Center for Biosystems Dynamics Research
-
- Liu, Yan
- Department of Chemistry, Graduate School of Science, Kyoto University
-
- Sanbo, Makoto
- Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences
-
- Miyazaki, Yuri
- Division of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences; Department of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies)
-
- Goto, Teppei
- Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences
-
- Abe, Manabu
- Department of Animal Model Development, Brain Research Institute, Niigata University
-
- Kassai, Hidetoshi
- Laboratory of Animal Resources, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo
-
- Sakimura, Kenji
- Department of Animal Model Development, Brain Research Institute, Niigata University
-
- Meijer, Dies
- Centre for Discovery Brain Sciences, University of Edinburgh
-
- Hirabayashi, Masumi
- Department of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies); Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences
-
- Fukai, Shuya
- Department of Chemistry, Graduate School of Science, Kyoto University
-
- Fukata, Masaki
- Division of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences; Department of Physiological Sciences, School of Life Science, SOKENDAI (The Graduate University for Advanced Studies)
Search this article
Description
What percentage of the protein function is required to prevent disease symptoms is a fundamental question in genetic disorders. Decreased transsynaptic LGI1-ADAM22 protein complexes, because of their mutations or autoantibodies, cause epilepsy and amnesia. However, it remains unclear how LGI1-ADAM22 levels are regulated and how much LGI1-ADAM22 function is required. Here, by genetic and structural analysis, we demonstrate that quantitative dual phosphorylation of ADAM22 by protein kinase A (PKA) mediates high-affinity binding of ADAM22 to dimerized 14-3-3. This interaction protects LGI1-ADAM22 from endocytosis-dependent degradation. Accordingly, forskolin-induced PKA activation increases ADAM22 levels. Leveraging a series of ADAM22 and LGI1 hypomorphic mice, we find that ∼50% of LGI1 and ∼10% of ADAM22 levels are sufficient to prevent lethal epilepsy. Furthermore, ADAM22 function is required in excitatory and inhibitory neurons. These results suggest strategies to increase LGI1-ADAM22 complexes over the required levels by targeting PKA or 14-3-3 for epilepsy treatment.
Journal
-
- Cell Reports
-
Cell Reports 37 (11), 110107-, 2021-12
Elsevier BV
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1050008998069335552
-
- NII Article ID
- 120007177780
-
- ISSN
- 22111247
-
- HANDLE
- 2433/266603
-
- PubMed
- 34910912
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- IRDB
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE